Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Yun-Ru Liu"'
Autor:
Ruo-Kai Lin, Chih-Ming Su, Shih-Yun Lin, Le Thi Anh Thu, Phui-Ly Liew, Jian-Yu Chen, Huey-En Tzeng, Yun-Ru Liu, Tzu-Hao Chang, Cheng-Yang Lee, Chin-Sheng Hung
Publikováno v:
Molecular Medicine, Vol 28, Iss 1, Pp 1-20 (2022)
Abstract Background Approximately 25% of patients with early-stage breast cancer experience cancer progression throughout the disease course. Alterations in TMEM240 in breast cancer were identified and investigated to monitor treatment response and d
Externí odkaz:
https://doaj.org/article/c18ac44cbf4f4316a04a4f5d72dbce83
Autor:
Wei-Chih Su, Yi-Chen Tsai, Hsiang-Lin Tsai, Tsung-Kun Chang, Tzu-Chieh Yin, Ching-Wen Huang, Yen-Cheng Chen, Ching-Chun Li, Po-Jung Chen, Yun-Ru Liu, Tsung-Han Hsieh, Jaw-Yuan Wang
Publikováno v:
Current Issues in Molecular Biology, Vol 44, Iss 4, Pp 1552-1563 (2022)
Personalized treatments based on the genetic profiles of tumors can simultaneously optimize efficacy and minimize toxicity, which is beneficial for improving patient outcomes. This study aimed to integrate gene alterations associated with predictive
Externí odkaz:
https://doaj.org/article/be391802ddaa4c7b806bb867d711857e
Autor:
Ching-Feng Chiu, Ji Min Park, Hsin-Hua Chen, Chen-Zou Mau, Pai-Sheng Chen, Yen-Hao Su, Hsin-An Chen, Yun-Ru Liu, Tsung-Han Hsieh, Chien-Chao Chiu, Shao-Wen Hung, Cheng-Yi Kuo, Young-Mao Chen, Chi-Fen Chang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 153, Iss , Pp 113520- (2022)
Oxaliplatin, a third-generation platinum derivative, has become one of the main chemotherapeutic treatments for esophagus, gastric and colorectal cancer; however, it is still unclear the potential effectiveness for pancreatic ductal adenocarcinoma (P
Externí odkaz:
https://doaj.org/article/75a78c224ec1452c9ae4ac7e5785c4ae
Autor:
Gilbert Aaron Lee, Hong-Wei Zhao, Yu-Wei Chang, Chia-Jung Lee, Yu-Chen S. H. Yang, Ying-Chieh Wu, Wan-Li Lin, Yun-Ru Liu, De-Shan Ning, Sung-Hui Tseng
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Mushrooms and Chinese traditional herbs have bioactive nutraceuticals with multiple therapeutic functions, including antioxidant and antibacterial activities and microbiome modulation properties. Mushroom-derived bioactive compounds are used in medic
Externí odkaz:
https://doaj.org/article/3a865482a8d9461aaad1d97c74bff773
Autor:
Chun-Hsu Pan, Shu-Chen Chien, Chang-Jui Chen, Chun-Ming Shih, Ming-Hsiung Hsieh, Chun-Yao Huang, Wei-Fung Bi, Chao-Shun Chan, Yung-Ta Kao, Cheng-Yi Hsiao, Shuo-Ju Chiang, Kuang-Hsing Chiang, Jen-Hung Huang, Yun-Ru Liu, Ji-Dung Luo, Hui-Yu Huang, Chieh-Hsi Wu
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Patients who receive percutaneous coronary intervention (PCI) have different chances of developing in-stent restenosis (ISR). To date, no predictable biomarker can be applied in the clinic. MicroRNAs (miRNAs or miRs) play critical
Externí odkaz:
https://doaj.org/article/28b563f3da134c64b478cb0c6cfb6513
Autor:
Gilbert Aaron Lee, Yu-Wei Chang, Wan-Li Lin, Yu-Chen S. H. Yang, Wei-Jen Chen, Fu-Huan Huang, Yun-Ru Liu
Publikováno v:
Microorganisms, Vol 11, Iss 2, p 278 (2023)
Rotavirus infections result in severe gastroenteritis with a detrimental inflammatory response in the intestine. Because probiotics have an anti-inflammatory effect and can modulate the gut microbiota profile, they can be used as a biotherapy for inf
Externí odkaz:
https://doaj.org/article/f0e6629706b24bc59d23b3c8003b9458
Autor:
Chien-Tai Hong, Lung Chan, Kai-Yun Chen, Hsun-Hua Lee, Li-Kai Huang, Yu-Chen S. H. Yang, Yun-Ru Liu, Chaur-Jong Hu
Publikováno v:
Cells, Vol 11, Iss 21, p 3468 (2022)
Patients with Parkinson’s disease (PD) exhibit distinct gut microbiota, which may promote gut-derived inflammation. Rifaximin is a nonabsorbable antibiotic that can modify gut microbiota. The present study investigated the effect of rifaximin on gu
Externí odkaz:
https://doaj.org/article/9c4c327bf9a347f196e7961010a4807f
Autor:
Chia-Ling Hsieh, Che-Ming Liu, Hsin-An Chen, Shun-Tai Yang, Katsumi Shigemura, Koichi Kitagawa, Fukashi Yamamichi, Masato Fujisawa, Yun-Ru Liu, Wei-Hua Lee, Kuan-Chou Chen, Chia-Ning Shen, Cheng-Chieh Lin, Leland W. K. Chung, Shian-Ying Sung
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Abstract Studies on the aberrant control of extracellular matrices (ECMs) have mainly focused on the role of malignant cells but less on that of stromal fibroblasts during cancer development. Herein, by using paired normal and prostate cancer-associa
Externí odkaz:
https://doaj.org/article/b3c9b9a6d5f74bdda45fa2a9e1e37c22
Autor:
Chien-Huang Liao, Yu-Tien Tzeng, Gi-Ming Lai, Chia-Lun Chang, Ming-Hung Hu, Wei-Lun Tsai, Yun-Ru Liu, Simon Hsia, Shuang-En Chuang, Tzeon-Jye Chiou, Le-Ming Wang, Jacqueline Whang-Peng, Chih-Jung Yao
Publikováno v:
Marine Drugs, Vol 18, Iss 8, p 399 (2020)
Non-small cell lung cancer (NSCLC)-carrying specific epidermal growth factor receptor (EGFR) mutations can be effectively treated by a tyrosine kinase inhibitor such as gefitinib. However, the inevitable development of acquired resistance leads to th
Externí odkaz:
https://doaj.org/article/1c629de0f26345eaab161d5f62289071
Autor:
Shian-Ying Sung, Junn-Liang Chang, Kuan-Chou Chen, Shauh-Der Yeh, Yun-Ru Liu, Yen-Hao Su, Chia-Yen Hsueh, Leland W K Chung, Chia-Ling Hsieh
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153350 (2016)
Stromal-epithelial interaction has been shown to promote local tumor growth and distant metastasis. We sought to create a promising gene therapy approach that co-targets cancer and its supporting stromal cells for combating castration-resistant prost
Externí odkaz:
https://doaj.org/article/00d6e1394c3e40229c35e7804a9aa7c4